speb/financial-data huggingface dataset:
CG.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 161653000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -21784000.00
CG.TO income_statement (quarterly, 2025-09-30) — Operating Income: 91976000.00
CG.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 377180000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 201642438.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 212000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 21004000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -28521000.00
CG.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 6955000.00
CG.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 257529000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 4392000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2356000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 2293000.00
CG.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -423000.00
CG.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 21535000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 489504000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 43931000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 6432000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Payables: 343177000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 343177000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 13090000.00
CG.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 351769000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: -207000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -24857000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -63011000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 192511000.00
CG.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 258731000.00
CG.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 36095000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -2229000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -22050000.00
CG.TO income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 0.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1168360000.00
CG.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 8074000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 49000.00
CG.TO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 3216000.00
CG.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 18245000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 201642438.00
CG.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: 209765000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 8074000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1939452000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1939452000.00
CG.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 43690712.12
CG.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 59581000.00
CG.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.17
CG.TO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 3177000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -7958000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 2689977000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1939452000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 17622000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1939452000.00
CG.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 303187000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 750525000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1619003000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 379715000.00
CG.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 328096000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 23368000.00
CG.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 257952000.00
CG.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 257952000.00
CG.TO cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -42600000.00
CG.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 700164000.00
CG.TO income_statement (annual, 2025-12-31) — +Operating Expense: 149366000.00
CG.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 53820000.00
CG.TO income_statement (annual, 2025-12-31) — +Total Revenue: 1384562000.00
CG.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 401557000.00
CG.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 150754000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 150754000.00
CG.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 127985000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 127985000.00
CG.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -796439000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -796439000.00
CG.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 30945000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 30945000.00
CG.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: -341110000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: -147590000.00
CG.TO balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 219425000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 219425000.00
CG.TO income_statement (annual, 2025-12-31) — Average Dilution Earnings: 0.00
CG.TO income_statement (quarterly, 2025-12-31) — Average Dilution Earnings: 1063000.00
CG.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 204662000.00
CG.TO income_statement (annual, 2025-12-31) — Basic EPS: 2.85
CG.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 624673000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 561796000.00
CG.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 1387278000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 1387278000.00
CG.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -296713000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -134252000.00
CG.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 18791000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 18791000.00
CG.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 727038000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 727038000.00
CG.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 528931000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 528931000.00
CG.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 540898000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 540898000.00
CG.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -41116000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -9990000.00
CG.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -140457000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -41012000.00
CG.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -303917000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -94916000.00
CG.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 348632000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 103063000.00
CG.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: 117200000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 38480000.00
CG.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -90493000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: -40310000.00
CG.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 7274000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -25394000.00
CG.TO cash_flow (annual, 2025-12-31) — Change In Payable: 117200000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: 42372000.00
CG.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 117200000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 42372000.00
CG.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -74275000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 2282000.00
CG.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -40294000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -21050000.00
CG.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -95742000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -32865000.00
CG.TO balance_sheet (annual, 2025-12-31) — Common Stock: 727038000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 727038000.00
CG.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -41116000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -9990000.00
CG.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2059762000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2059762000.00
CG.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 5412000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 2482000.00
CG.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -93689000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -29688000.00
CG.TO balance_sheet (annual, 2025-12-31) — Construction In Progress: 257375000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 257375000.00
CG.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 920769000.00
CG.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 238171000.00
CG.TO balance_sheet (annual, 2025-12-31) — Current Assets: 1070077000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 1070077000.00
CG.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 7924000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 7924000.00
CG.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 7924000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 7924000.00
CG.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 446903000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 446903000.00
CG.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 147018000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 64769000.00
CG.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 147018000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 64769000.00
CG.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 115636000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 27797000.00
CG.TO balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 82093000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 82093000.00
CG.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 205587000.00
CG.TO income_statement (annual, 2025-12-31) — Diluted EPS: 2.84
CG.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 583988000.00
CG.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 193835000.00
CG.TO balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 37519000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 37519000.00
CG.TO balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Non Current: 35070000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Non Current: 35070000.00
CG.TO income_statement (annual, 2025-12-31) — EBIT: 732452000.00
CG.TO income_statement (quarterly, 2025-12-31) — EBIT: 248045000.00
CG.TO income_statement (annual, 2025-12-31) — EBITDA: 848088000.00
CG.TO income_statement (quarterly, 2025-12-31) — EBITDA: 275842000.00
CG.TO balance_sheet (annual, 2025-12-31) — Employee Benefits: 2312000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 2312000.00
CG.TO cash_flow (annual, 2025-12-31) — End Cash Position: 528931000.00
CG.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 528931000.00
CG.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -140457000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -41012000.00
CG.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 144768000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 144768000.00
CG.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 51919000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -31189000.00
CG.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -50545000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: -12674000.00
CG.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 50545000.00
CG.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: 12674000.00
CG.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 200000.00
CG.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: -26000.00
CG.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 10983000.00
CG.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -22157000.00
CG.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -49363000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -49363000.00
CG.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 60233000.00
CG.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 25188000.00
CG.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 2396839000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2396839000.00
CG.TO income_statement (annual, 2025-12-31) — Gross Profit: 463793000.00
CG.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 163386000.00
CG.TO balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 2566000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 2566000.00
CG.TO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: -341110000.00
CG.TO income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: -147590000.00
CG.TO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 28879000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 28879000.00
CG.TO income_statement (annual, 2025-12-31) — Interest Expense: 1446000.00
CG.TO income_statement (quarterly, 2025-12-31) — Interest Expense: -9496000.00
CG.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1446000.00
CG.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: -9496000.00
CG.TO income_statement (annual, 2025-12-31) — Interest Income: 20797000.00
CG.TO income_statement (quarterly, 2025-12-31) — Interest Income: 4473000.00
CG.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 20797000.00
CG.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 4473000.00
CG.TO balance_sheet (annual, 2025-12-31) — Inventory: 333715000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 333715000.00
CG.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 2059762000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2059762000.00
CG.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -303917000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -94916000.00
CG.TO balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 219425000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 219425000.00
CG.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 219425000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 219425000.00
CG.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 5412000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 2482000.00
CG.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 10867000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 10867000.00
CG.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 10867000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 10867000.00
CG.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -11064000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -4825000.00
CG.TO balance_sheet (annual, 2025-12-31) — Long Term Provisions: 294452000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 294452000.00
CG.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 41044000.00
CG.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -88277000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -27206000.00
CG.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 3898000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 113000.00
CG.TO income_statement (annual, 2025-12-31) — Net Income: 583988000.00
CG.TO income_statement (quarterly, 2025-12-31) — Net Income: 192772000.00
CG.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 583988000.00
CG.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 192772000.00
CG.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 583988000.00
CG.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 192772000.00
CG.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 583988000.00
CG.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 192772000.00
CG.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 583988000.00
CG.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 192772000.00
CG.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 583988000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 192772000.00
CG.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 583988000.00
CG.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 192772000.00
CG.TO income_statement (annual, 2025-12-31) — Net Interest Income: 16946000.00
CG.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: 11564000.00
CG.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -48535000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -1701000.00
CG.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -11064000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -4825000.00
CG.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -11064000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -4825000.00
CG.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 16946000.00
CG.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 11564000.00
CG.TO balance_sheet (annual, 2025-12-31) — Net PPE: 1600400000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 1600400000.00
CG.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -296426000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -134259000.00
CG.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2059762000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2059762000.00
CG.TO balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 41483000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 41483000.00
CG.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 24899000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 24899000.00
CG.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 62261000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 62261000.00
CG.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 24362000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 24362000.00
CG.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 24899000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 24899000.00
CG.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 37899000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 37899000.00
CG.TO balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2312000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2312000.00
CG.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 445250000.00
CG.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 137761000.00
CG.TO income_statement (annual, 2025-12-31) — Normalized Income: 262167716.80
CG.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 89416998.15
CG.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 348632000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 103063000.00
CG.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -46647000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -12561000.00
CG.TO income_statement (annual, 2025-12-31) — Operating Income: 314427000.00
CG.TO income_statement (quarterly, 2025-12-31) — Operating Income: 109566000.00
CG.TO income_statement (annual, 2025-12-31) — Operating Revenue: 1306615000.00
CG.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 370708000.00
CG.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 199806355.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 199806355.00
CG.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 554000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 554000.00
CG.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 40406000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 40406000.00
CG.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -49363000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -49363000.00
CG.TO income_statement (annual, 2025-12-31) — Other Gand A: 32369000.00
CG.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 8269000.00
CG.TO income_statement (annual, 2025-12-31) — Other Income Expense: 399633000.00
CG.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 136411000.00
CG.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 291000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -8730000.00
CG.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 2366000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 2366000.00
CG.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -3205000.00
CG.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -1670000.00
CG.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 58740000.00
CG.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 21261000.00
CG.TO balance_sheet (annual, 2025-12-31) — Other Payable: 201183000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 201183000.00
CG.TO balance_sheet (annual, 2025-12-31) — Other Properties: 122857000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 122857000.00
CG.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 3793000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 3793000.00
CG.TO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 11967000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 11967000.00
CG.TO balance_sheet (annual, 2025-12-31) — Payables: 380816000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Payables: 380816000.00
CG.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 380816000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 380816000.00
CG.TO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 17757000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 17757000.00
CG.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 17309000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 17309000.00
CG.TO income_statement (annual, 2025-12-31) — Pretax Income: 731006000.00
CG.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 257541000.00
CG.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -48535000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -1701000.00
CG.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -296713000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -134252000.00
CG.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 188947000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 188947000.00
CG.TO balance_sheet (annual, 2025-12-31) — Receivables: 175035000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 175035000.00
CG.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 920769000.00
CG.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 238171000.00
CG.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 115636000.00
CG.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 27797000.00
CG.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -11064000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -4825000.00
CG.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -93689000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -29688000.00
CG.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 1351142000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1351142000.00
CG.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 27864000.00
CG.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 16919000.00
CG.TO cash_flow (annual, 2025-12-31) — Sale Of Business: 41044000.00
CG.TO cash_flow (annual, 2025-12-31) — Sale Of PPE: 287000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Sale Of PPE: -7000.00
CG.TO income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 11324000.00
CG.TO income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 2608000.00
CG.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 71557000.00
CG.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 27796000.00
CG.TO balance_sheet (annual, 2025-12-31) — Share Issued: 199806355.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 199806355.00
CG.TO income_statement (annual, 2025-12-31) — Special Income Charges: 391855000.00
CG.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: 160238000.00
CG.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 21657000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 10712000.00
CG.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2059762000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2059762000.00
CG.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2059762000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2059762000.00
CG.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 81017716.80
CG.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 34725998.15
CG.TO income_statement (annual, 2025-12-31) — Tax Provision: 147018000.00
CG.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 64769000.00
CG.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.20
CG.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
CG.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 5738000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 5738000.00
CG.TO cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -88908000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -32119000.00
CG.TO balance_sheet (annual, 2025-12-31) — Total Assets: 2958650000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 2958650000.00
CG.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 2059762000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2059762000.00
CG.TO balance_sheet (annual, 2025-12-31) — Total Debt: 18791000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 18791000.00
CG.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2059762000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2059762000.00
CG.TO income_statement (annual, 2025-12-31) — Total Expenses: 1070135000.00
CG.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 291991000.00
CG.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 898888000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 898888000.00
CG.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1888573000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1888573000.00
CG.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 451985000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 451985000.00
CG.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 669746000.00
CG.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 242265000.00
CG.TO income_statement (annual, 2025-12-31) — Total Other Finance Cost: 2405000.00
CG.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 28879000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 28879000.00
CG.TO income_statement (annual, 2025-12-31) — Total Unusual Items: 402838000.00
CG.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 138081000.00
CG.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 402838000.00
CG.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 138081000.00
CG.TO cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -2999000.00
CG.TO cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 26101000.00
CG.TO balance_sheet (annual, 2025-12-31) — Working Capital: 623174000.00
CG.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 623174000.00
CG.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 50331000.00
CG.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 484694000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 369463000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 134217000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 29458000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 211684000.00
CG.TO income_statement (quarterly, 2026-03-31) — Average Dilution Earnings: 0.00
CG.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 199607000.00
CG.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.40
CG.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 528931000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 792411000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -71084000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 43734000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 713357000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 543491000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 554511000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -10121000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -35159000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -70375000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 120094000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -50550000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 2078000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 3967000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 2683000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -41822000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 14560000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 713357000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -10121000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2097176000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 1436000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -22466000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 282070000.00
CG.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 287083000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 1132510000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 8201000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 8201000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 470791000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Current Provisions: 593000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 53198000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 53198000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 34103000.00
CG.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 201490000.00
CG.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.39
CG.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 79431000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 45814000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Non Current: 42889000.00
CG.TO income_statement (quarterly, 2026-03-31) — EBIT: 137334000.00
CG.TO income_statement (quarterly, 2026-03-31) — EBITDA: 171437000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 2390000.00
CG.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 543491000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -35159000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 49010000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: -16114000.00
CG.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Business: 16114000.00
CG.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -28639000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -66091000.00
CG.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 24260000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1666323000.00
CG.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 197611000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 51685000.00
CG.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 4705000.00
CG.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 4705000.00
CG.TO income_statement (quarterly, 2026-03-31) — Interest Income: 4194000.00
CG.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 4194000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 381298000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2097176000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -70375000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 211684000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 211684000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 1436000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 35533000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 35533000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -4008000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 293704000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -21030000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -2131000.00
CG.TO income_statement (quarterly, 2026-03-31) — Net Income: 79431000.00
CG.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 79431000.00
CG.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 79431000.00
CG.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 79431000.00
CG.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 79431000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 79431000.00
CG.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 79431000.00
CG.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -511000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 709000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -4008000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -4008000.00
CG.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -511000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 1666323000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -71084000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2097176000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 49511000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 12832000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 52130000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 24530000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 12832000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 27600000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 2390000.00
CG.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 183962000.00
CG.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 86946000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 120094000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -18245000.00
CG.TO income_statement (quarterly, 2026-03-31) — Operating Income: 147280000.00
CG.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 485314000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 199016241.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 960000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 40849000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -66091000.00
CG.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 12596000.00
CG.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: -14140000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 4793000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 2356000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 123492000.00
CG.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1615000.00
CG.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 18418000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 51526000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 11020000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Payables: 421148000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 421148000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 15710000.00
CG.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 132629000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -5292000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -71084000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 180031000.00
CG.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 287083000.00
CG.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 34103000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -4008000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -22466000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1420452000.00
CG.TO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 11664000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 6001000.00
CG.TO income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 3024000.00
CG.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 27284000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 199016241.00
CG.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: 16114000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: -5240000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2097176000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2097176000.00
CG.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -5010000.00
CG.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 53198000.00
CG.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CG.TO cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -24624000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 3075216000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2097176000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 43734000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2097176000.00
CG.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 337414000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 978040000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1942706000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 507249000.00
CG.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 108780000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 51685000.00
CG.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -12525000.00
CG.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -12525000.00
CG.TO cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 38500000.00
CG.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 661719000.00
CG1.AX income_statement (annual, 2021-06-30) — +Operating Expense: 9173019.00
CG1.AX income_statement (annual, 2021-06-30) — +Total Revenue: 12197153.00
CG1.AX balance_sheet (annual, 2021-06-30) — Accounts Payable: 1648357.00
CG1.AX balance_sheet (annual, 2021-06-30) — Accounts Receivable: 1217978.00
CG1.AX balance_sheet (annual, 2021-06-30) — Accumulated Depreciation: -3514817.00
CG1.AX income_statement (annual, 2021-06-30) — Amortization: 163015.00
CG1.AX income_statement (annual, 2021-06-30) — Amortization Of Intangibles Income Statement: 163015.00
CG1.AX income_statement (annual, 2021-06-30) — Basic Average Shares: 135959282.00
CG1.AX income_statement (annual, 2021-06-30) — Basic EPS: -0.04
CG1.AX cash_flow (annual, 2021-06-30) — Beginning Cash Position: 312765.00
CG1.AX cash_flow (annual, 2021-06-30) — Capital Expenditure: -1511641.00
CG1.AX balance_sheet (annual, 2021-06-30) — Capital Lease Obligations: 2539741.00
CG1.AX balance_sheet (annual, 2021-06-30) — Capital Stock: 76789766.00
CG1.AX balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 1645579.00
CG1.AX balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 1645579.00
CG1.AX balance_sheet (annual, 2021-06-30) — Cash Equivalents: 60419.00
CG1.AX balance_sheet (annual, 2021-06-30) — Cash Financial: 1585160.00
CG1.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Financing Activities: 5526306.00
CG1.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Investing Activities: -1511641.00
CG1.AX cash_flow (annual, 2021-06-30) — Cash Flowsfromusedin Operating Activities Direct: -2613066.00
CG1.AX cash_flow (annual, 2021-06-30) — Changes In Cash: 1401599.00
CG1.AX cash_flow (annual, 2021-06-30) — Classesof Cash Payments: -15700559.00
CG1.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 13086737.00
CG1.AX balance_sheet (annual, 2021-06-30) — Common Stock: 76789766.00
CG1.AX balance_sheet (annual, 2021-06-30) — Common Stock Equity: 8378608.00
CG1.AX cash_flow (annual, 2021-06-30) — Common Stock Issuance: 8195588.00
CG1.AX cash_flow (annual, 2021-06-30) — Common Stock Payments: -552040.00
CG1.AX balance_sheet (annual, 2021-06-30) — Construction In Progress: 112155.00
CG1.AX income_statement (annual, 2021-06-30) — Cost Of Revenue: 8935477.00
CG1.AX balance_sheet (annual, 2021-06-30) — Current Assets: 4825346.00
CG1.AX balance_sheet (annual, 2021-06-30) — Current Capital Lease Obligation: 1222044.00
CG1.AX balance_sheet (annual, 2021-06-30) — Current Debt: 4853675.00
CG1.AX balance_sheet (annual, 2021-06-30) — Current Debt And Capital Lease Obligation: 6075719.00
CG1.AX balance_sheet (annual, 2021-06-30) — Current Liabilities: 8348131.00
CG1.AX income_statement (annual, 2021-06-30) — Depreciation Amortization Depletion Income Statement: 1693775.00
CG1.AX income_statement (annual, 2021-06-30) — Depreciation And Amortization In Income Statement: 1693775.00
CG1.AX income_statement (annual, 2021-06-30) — Depreciation Income Statement: 1530760.00
CG1.AX income_statement (annual, 2021-06-30) — Diluted Average Shares: 135959282.00
CG1.AX income_statement (annual, 2021-06-30) — Diluted EPS: -0.04